| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |